Lipocine (LPCN) Stock Price, Quote, News & History | Benzinga

Lipocine Inc (LPCN) Stock Price, Quote, News & History

LPCNNASDAQ

Trade with Public

Trade with Public

$2.33

-0.01-0.43%

At close: Jun 18, 5:00 PM EST

$2.35

0.020.86%

After Hours: 9:12 AM EST

OverviewNews Earnings Events Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$2.35

Close

$2.33

Volume / Avg.

122.36K / 387.38K

Day Range

$2.29 - $2.50

52 Wk Range

1.81 - 12.37

Market Cap

$19.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

1.12%

Days to Cover

1.08

Recent Lipocine Inc News

What's Going On With Carvana Stock Monday?

BofA downgrades Carvana (CVNA) to Neutral, cutting the price target to $360. Explore the latest analyst insights and technical support levels.

Lekha Gupta

What's Going On With Lipocine Stock On Monday?

Lipocine stock rebounds after a steep drop as LPCN 1154 misses the Phase 3 endpoint, with encouraging subgroup data.

Vandana Singh

Lipocine Stock Plunges After LPCN 1154 Misses Phase 3 Primary Endpoint

Lipocine Inc. shares are trading lower Thursday after reporting topline safety and efficacy results for LPCN 1154 in postpartum depression.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.05M

Investing Cash Flow (TTM)

-3.13M

Financing Cash Flow (TTM)

14.84M

Free Cash Flow (TTM)

-10.05M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

1.66M

Analyst Trends and Forecast

1

Jan

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$5.44M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.09

PB Ratio (TTM)

0.84

Earnings Yield % (TTM)

-83.76%

Earnings Yield % (FWD)

-81.41%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.77

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.02M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.35

Close

$2.33

Volume / Avg.

122.36K / 387.38K

Day Range

$2.29 - $2.50

52 Wk Range

1.81 - 12.37

Market Cap

$19.37M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

1.12%

Days to Cover

1.08

About

Sector

Health Care

Industry

Pharmaceuticals

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing dru...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Lipocine (LPCN) stock?

A

You can purchase shares of Lipocine (NASDAQ:LPCN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lipocine (LPCN) competitors?

A

There are no as such competitors for Lipocine.

Q

What is the forecast, or price target, for Lipocine (LPCN) stock?

A

Lipocine has a consensus price target of $21.50.

Q

What is the current price for Lipocine (LPCN)?

A

The stock price for Lipocine (NASDAQ: LPCN) is $2.35 last updated June 18, 2026 at 9:12 AM EDT.

Q

Does Lipocine (LPCN) pay a dividend?

A

There are no upcoming dividends for Lipocine.

Q

When is Lipocine (NASDAQ:LPCN) reporting earnings?

A

Lipocine does not have any upcoming earnings scheduled.

Q

Is Lipocine (LPCN) going to split?

A

There is no upcoming split for Lipocine.

Q

What sector and industry does Lipocine (LPCN) operate in?

A

Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.